BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2068152)

  • 1. Plasma neuropeptide Y (NPY): a novel marker of neuroblastoma.
    Kogner P; Theodorsson E; Björk O
    Prog Clin Biol Res; 1991; 366():367-73. PubMed ID: 2068152
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of plasma neuropeptide Y (NPY) in diagnosis and prognosis of neuroblastoma.
    Hayashi Y; Ohi R; Sone M; Takahashi K; Mouri T; Watanabe T; Yaoita S; Nakamura M
    Prog Clin Biol Res; 1991; 366():359-65. PubMed ID: 2068151
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of neuropeptide Y in pediatric neural crest tumors: relation to tumor malignancy and genetic findings.
    Kogner P; Björk O; Hedborg F; Nordenskjöld A; Nordenskjöld M; Söderhäll S; Theodorsson E
    Prog Clin Biol Res; 1991; 366():351-7. PubMed ID: 2068150
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuropeptide Y as a marker in pediatric neuroblastoma.
    Kogner P; Björk O; Theodorsson E
    Pediatr Pathol; 1990; 10(1-2):207-16. PubMed ID: 2315229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W
    Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial measurements of neuropeptide Y in plasma for monitoring neuroblastoma in children.
    Rascher W; Kremens B; Wagner S; Feth F; Hunneman DH; Lang RE
    J Pediatr; 1993 Jun; 122(6):914-6. PubMed ID: 8501569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of neuron specific enolase in the prognosis and followup of neuroblastoma in children. Results of a retrospective series of 21 patients].
    Abdennebi M; Boussen H; Harzallah L; Daldoul O; Ghanem A; Gamoudi A; Ben Slimene F; Rahal K; el May A; Ben Ayed F; Guemira F
    Tunis Med; 2000 Feb; 78(2):106-8. PubMed ID: 10894045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
    Mouri T; Sone M; Takahashi K; Itoi K; Totsune K; Hayashi Y; Hasegawa S; Ohneda M; Murakami O; Miura Y
    Clin Sci (Lond); 1992 Aug; 83(2):205-11. PubMed ID: 1327637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The late recurrence of ganglioneuroma 21 years after initial presentation with neuroblastoma.
    Okita Y; Narita Y; Yoshida A; Miyakita Y; Ohno M; Saio M; Yoshimi N; Shibui S
    Pediatr Hematol Oncol; 2012 Oct; 29(7):647-51. PubMed ID: 22966943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma: biology, prognosis, and treatment.
    Park JR; Eggert A; Caron H
    Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composite ganglioneuroblastoma. An assessment of the significance of histological maturation in neuroblastoma diagnosed beyond infancy.
    Bove KE; McAdams AJ
    Arch Pathol Lab Med; 1981 Jun; 105(6):325-30. PubMed ID: 6894529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y in neuroblastoma: increased concentration in metastasis, release during surgery, and characterization of plasma and tumor extracts.
    Kogner P; Björk O; Theodorsson E
    Med Pediatr Oncol; 1993; 21(5):317-22. PubMed ID: 8492745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological diagnosis of brain tumors: (3) Gangliocytoma (ganglioglioma)].
    Tamura M
    No Shinkei Geka; 1989 Apr; 17(4):311-7. PubMed ID: 2671773
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors.
    Grouzmann E; Comoy E; Bohuon C
    J Clin Endocrinol Metab; 1989 Apr; 68(4):808-13. PubMed ID: 2466046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleomorphic (anaplastic) neuroblastoma.
    Cozzutto C; Carbone A
    Arch Pathol Lab Med; 1988 Jun; 112(6):621-5. PubMed ID: 3377661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological cellular phenotype and the prognosis in neuroblastoma in children].
    Novikov AM; Blinov VM; Bukhny AF; Bassalyk LS
    Vopr Onkol; 1990; 36(6):693-7. PubMed ID: 2378089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular biology and genetics of neuroblastoma.
    Tay JS
    J Singapore Paediatr Soc; 1991; 33(3-4):80-7. PubMed ID: 1812339
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumors of the neuroblastoma group.
    Shimada H
    Pathology (Phila); 1993; 2(1):43-59. PubMed ID: 9420930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropeptide Y].
    Kawakami Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():421-4. PubMed ID: 16149544
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroblastoma: biological markers, surgery, and clinical course].
    Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
    Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.